Two Injectables to Require Prior Authorization Beginning March 1
Beginning March 1, 2023, two injectable drugs will require prior authorization. The following codes will be added to Highmark’s List of Procedures/DME Requiring Authorization on March 1:
|J7331||1% sodium hyaluronate||SynoJoynt|
Please note: These drugs will not appear on the authorization-required list or require authorization until the March 1 effective date.
Authorization for these drugs should be submitted through NaviNet.
For more information about requesting prior authorization or viewing the current authorization-required list, please visit the Provider Resource Center > Claims, Payment & Reimbursement > Procedures/Service Requiring Prior Authorization.